Selected research
Industry Research
Surgical Hemostatic Agents Industry Research Report 2026
Market perspective
The global Surgical Hemostatic Agents market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Surgical Hemostatic Agents is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Surgical Hemostatic Agents is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Surgical Hemostatic Agents is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Surgical Hemostatic Agents include J&J, Advance Medical Solution, B Braun, BD, CryoLife, CSL Behring, Equimedical, Ferrosan Medical Devices and Gelita, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Surgical Hemostatic Agents market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Surgical Hemostatic Agents Market by Company
J&J
Advance Medical Solution
B Braun
BD
CryoLife
CSL Behring
Equimedical
Ferrosan Medical Devices
Gelita
Marine Polymer
Z-Medica
Baxter
Pfizer
Medtronic
Surgical Hemostatic Agents Segment by Type
Gelation Hemostats
Combination Hemostats
Others
Surgical Hemostatic Agents Segment by Application
Hospitals
Surgical Centers
Other
Surgical Hemostatic Agents Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surgical Hemostatic Agents market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Surgical Hemostatic Agents and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surgical Hemostatic Agents.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Surgical Hemostatic Agents manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Surgical Hemostatic Agents by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Surgical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Gelation Hemostats
- Combination Hemostats
- Others
Applications
- Hospitals
- Surgical Centers
- Other
Companies covered
- J&J
- Advance Medical Solution
- B Braun
- BD
- CryoLife
- CSL Behring
- Equimedical
- Ferrosan Medical Devices
- Gelita
- Marine Polymer
- Z-Medica
- Baxter
- Pfizer
- Medtronic
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Surgical Hemostatic Agents Market Size (2021-2032)
- 2.2.2 Global Surgical Hemostatic Agents Sales (2021-2032)
- 2.2.3 Global Surgical Hemostatic Agents Market Average Price (2021-2032)
- 2.3 Surgical Hemostatic Agents by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Gelation Hemostats
- 2.3.3 Combination Hemostats
- 2.3.4 Others
- 2.4 Surgical Hemostatic Agents by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Surgical Centers
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Surgical Hemostatic Agents Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Surgical Hemostatic Agents Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Surgical Hemostatic Agents Revenue of Manufacturers (2021-2026)
- 3.4 Global Surgical Hemostatic Agents Average Price by Manufacturers (2021-2026)
- 3.5 Global Surgical Hemostatic Agents Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Surgical Hemostatic Agents, Product Type & Application
- 3.8 Global Manufacturers of Surgical Hemostatic Agents, Established Date
- 3.9 Global Surgical Hemostatic Agents Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 J&J
- 4.1.1 J&J Company Information
- 4.1.2 J&J Business Overview
- 4.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 J&J Surgical Hemostatic Agents Product Portfolio
- 4.1.5 J&J Recent Developments
- 4.2 Advance Medical Solution
- 4.2.1 Advance Medical Solution Company Information
- 4.2.2 Advance Medical Solution Business Overview
- 4.2.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Advance Medical Solution Surgical Hemostatic Agents Product Portfolio
- 4.2.5 Advance Medical Solution Recent Developments
- 4.3 B Braun
- 4.3.1 B Braun Company Information
- 4.3.2 B Braun Business Overview
- 4.3.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 B Braun Surgical Hemostatic Agents Product Portfolio
- 4.3.5 B Braun Recent Developments
- 4.4 BD
- 4.4.1 BD Company Information
- 4.4.2 BD Business Overview
- 4.4.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BD Surgical Hemostatic Agents Product Portfolio
- 4.4.5 BD Recent Developments
- 4.5 CryoLife
- 4.5.1 CryoLife Company Information
- 4.5.2 CryoLife Business Overview
- 4.5.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 CryoLife Surgical Hemostatic Agents Product Portfolio
- 4.5.5 CryoLife Recent Developments
- 4.6 CSL Behring
- 4.6.1 CSL Behring Company Information
- 4.6.2 CSL Behring Business Overview
- 4.6.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CSL Behring Surgical Hemostatic Agents Product Portfolio
- 4.6.5 CSL Behring Recent Developments
- 4.7 Equimedical
- 4.7.1 Equimedical Company Information
- 4.7.2 Equimedical Business Overview
- 4.7.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Equimedical Surgical Hemostatic Agents Product Portfolio
- 4.7.5 Equimedical Recent Developments
- 4.8 Ferrosan Medical Devices
- 4.8.1 Ferrosan Medical Devices Company Information
- 4.8.2 Ferrosan Medical Devices Business Overview
- 4.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio
- 4.8.5 Ferrosan Medical Devices Recent Developments
- 4.9 Gelita
- 4.9.1 Gelita Company Information
- 4.9.2 Gelita Business Overview
- 4.9.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Gelita Surgical Hemostatic Agents Product Portfolio
- 4.9.5 Gelita Recent Developments
- 4.10 Marine Polymer
- 4.10.1 Marine Polymer Company Information
- 4.10.2 Marine Polymer Business Overview
- 4.10.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Marine Polymer Surgical Hemostatic Agents Product Portfolio
- 4.10.5 Marine Polymer Recent Developments
- 4.11 Z-Medica
- 4.11.1 Z-Medica Company Information
- 4.11.2 Z-Medica Business Overview
- 4.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Z-Medica Surgical Hemostatic Agents Product Portfolio
- 4.11.5 Z-Medica Recent Developments
- 4.12 Baxter
- 4.12.1 Baxter Company Information
- 4.12.2 Baxter Business Overview
- 4.12.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Baxter Surgical Hemostatic Agents Product Portfolio
- 4.12.5 Baxter Recent Developments
- 4.13 Pfizer
- 4.13.1 Pfizer Company Information
- 4.13.2 Pfizer Business Overview
- 4.13.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Pfizer Surgical Hemostatic Agents Product Portfolio
- 4.13.5 Pfizer Recent Developments
- 4.14 Medtronic
- 4.14.1 Medtronic Company Information
- 4.14.2 Medtronic Business Overview
- 4.14.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Medtronic Surgical Hemostatic Agents Product Portfolio
- 4.14.5 Medtronic Recent Developments
5 Global Surgical Hemostatic Agents Market Scenario by Region
- 5.1 Global Surgical Hemostatic Agents Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Surgical Hemostatic Agents Sales by Region: 2021-2032
- 5.2.1 Global Surgical Hemostatic Agents Sales by Region: 2021-2026
- 5.2.2 Global Surgical Hemostatic Agents Sales by Region: 2027-2032
- 5.3 Global Surgical Hemostatic Agents Revenue by Region: 2021-2032
- 5.3.1 Global Surgical Hemostatic Agents Revenue by Region: 2021-2026
- 5.3.2 Global Surgical Hemostatic Agents Revenue by Region: 2027-2032
- 5.4 North America Surgical Hemostatic Agents Market Facts & Figures by Country
- 5.4.1 North America Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Surgical Hemostatic Agents Sales by Country (2021-2032)
- 5.4.3 North America Surgical Hemostatic Agents Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Surgical Hemostatic Agents Market Facts & Figures by Country
- 5.5.1 Europe Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Surgical Hemostatic Agents Sales by Country (2021-2032)
- 5.5.3 Europe Surgical Hemostatic Agents Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Surgical Hemostatic Agents Market Facts & Figures by Country
- 5.6.1 Asia Pacific Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Surgical Hemostatic Agents Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Surgical Hemostatic Agents Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Surgical Hemostatic Agents Market Facts & Figures by Country
- 5.7.1 South America Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Surgical Hemostatic Agents Sales by Country (2021-2032)
- 5.7.3 South America Surgical Hemostatic Agents Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Surgical Hemostatic Agents Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Surgical Hemostatic Agents Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Surgical Hemostatic Agents Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Surgical Hemostatic Agents Sales by Type (2021-2032)
- 6.1.1 Global Surgical Hemostatic Agents Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Surgical Hemostatic Agents Sales Market Share by Type (2021-2032)
- 6.2 Global Surgical Hemostatic Agents Revenue by Type (2021-2032)
- 6.2.1 Global Surgical Hemostatic Agents Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Surgical Hemostatic Agents Revenue Market Share by Type (2021-2032)
- 6.3 Global Surgical Hemostatic Agents Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Surgical Hemostatic Agents Sales by Application (2021-2032)
- 7.1.1 Global Surgical Hemostatic Agents Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Surgical Hemostatic Agents Sales Market Share by Application (2021-2032)
- 7.2 Global Surgical Hemostatic Agents Revenue by Application (2021-2032)
- 7.2.1 Global Surgical Hemostatic Agents Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Surgical Hemostatic Agents Revenue Market Share by Application (2021-2032)
- 7.3 Global Surgical Hemostatic Agents Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Surgical Hemostatic Agents Value Chain Analysis
- 8.1.1 Surgical Hemostatic Agents Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Surgical Hemostatic Agents Production Mode & Process
- 8.2 Surgical Hemostatic Agents Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Surgical Hemostatic Agents Distributors
- 8.2.3 Surgical Hemostatic Agents Customers
9 Global Surgical Hemostatic Agents Analyzing Market Dynamics
- 9.1 Surgical Hemostatic Agents Industry Trends
- 9.2 Surgical Hemostatic Agents Industry Drivers
- 9.3 Surgical Hemostatic Agents Industry Opportunities and Challenges
- 9.4 Surgical Hemostatic Agents Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst